Kyle Kitchen, PharmD, MBA
Articles
June 11th 2025
Subcutaneous Value: Efficiency and Access
Andre D. Harvin, PharmD, MS, MBA Raghava Reddy Induru, MD Kyle Kitchen, PharmD, MBA Nicholas Bouchard, PharmD Diane Bohn, MS, RN, ANP-BC
Panelists discuss how subcutaneous (SubQ) drug formulations offer practical value by significantly reducing treatment times, easing staffing pressures, and enhancing efficiency in oncology practices, ultimately supporting a more scalable and sustainable care model.
June 11th 2025
The Shifting to Subcutaneous Oncology: Recent FDA Approvals
Andre D. Harvin, PharmD, MS, MBA Raghava Reddy Induru, MD Kyle Kitchen, PharmD, MBA Nicholas Bouchard, PharmD Diane Bohn, MS, RN, ANP-BC
Panelists discuss how the shift from intravenous (IV) to subcutaneous (SubQ) drug administration is transforming oncology care delivery, highlighting its lasting impact on patient experience, health care efficiency, and clinical workflows in light of recent FDA approvals and evolving pharmaceutical strategies.
Latest Updated Articles
Published: February 20th 2025 | Updated: February 21st 2025
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
Published: January 16th 2025 | Updated: January 29th 2025
FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
